SOMERSET, NJ–(Marketwired – May 17, 2017) – MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, today announced that Saint Clare’s Health, an award-winning health system based in New Jersey, has significantly expanded its relationship with MTBC’s subsidiary to include the majority of its physician groups and new service lines.
Karl Johnson, MTBC SVP, Sales and Marketing, said, “The hospital seeks to consolidate the billing with one professional billing company and we’re very pleased that our strong relationship and operational successes resulted in our selection for these additional physician groups.” He continued, “The fulfillment of the mission of Saint Clare’s Health ensures that area residents can continue to access top quality healthcare services and we’re pleased to support them in fulfilling their mission as we expand our existing relationship with Saint Clare’s Health.”
Saint Clare’s Health, a member of Prime Healthcare Services, is comprised of a network of hospitals and healthcare facilities including Denville Hospital, Dover Hospital, Sussex Health Center, and various satellite offices. With the latest expansion of MTBC’s relationship with Saint Clare’s Health, which is contracted through MTBC’s subsidiary MediGain Practice Management, the scope and volume of its business with Saint Clare’s Health is expected to significantly increase.
Healthcare practices and hospitals throughout the country leverage MTBC’s proprietary healthcare IT platform and services to optimize revenues, reduce expenses and streamline workflows. As a result of its WFS and MediGain acquisitions, MTBC, which has traditionally focused on the small practice segment of the market, expanded its suite of services to support the unique workflows of larger practices and hospitals. MTBC, which experienced greater than 60% YoY revenue growth during the two most recent quarters, supports more than 2,700 healthcare providers across the country practicing in a variety of more than 60 unique specialties and subspecialties.
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to: the Company’s ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Investor and Company Contact:
Chief Financial Officer
Medical Transcription Billing, Corp.